{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:16:56Z","timestamp":1762345016076,"version":"build-2065373602"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,5]]},"DOI":"10.7759\/cureus.96131","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:13:37Z","timestamp":1762344817000},"source":"Crossref","is-referenced-by-count":0,"title":["Decoding Hyponatremia: A Systematic Review of Diagnostic Pathways and Therapeutic Approaches Applied When Correction Fails"],"prefix":"10.7759","author":[{"given":"Kiranjot","family":"Kaur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharmila","family":"Venkatachalapathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mashal","family":"Mumtaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Faizan","family":"Butt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirna Morad","family":"Mashhour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shashwat","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed Usman Khan","family":"Wazir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neiloofar","family":"Mohmand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayesha","family":"Farooqi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00063-012-0120-3","article-title":"Hyponatremia [Article in German]","volume":"108","author":"Heinrich S","year":"2013","unstructured":"Heinrich S, Wagner A, Gross P. Hyponatremia [Article in German]. Med Klin Intensivmed Notfmed. 2013, 108:53-8. 10.1007\/s00063-012-0120-3","journal-title":"Med Klin Intensivmed Notfmed"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.09.026","article-title":"Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits","volume":"119","author":"Renneboog B","year":"2006","unstructured":"Renneboog B, Musch W, Vandemergel X, Manto MU, Decaux G. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med. 2006, 119:71.e1-8. 10.1016\/j.amjmed.2005.09.026","journal-title":"Am J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200005253422107","article-title":"Hyponatremia","volume":"342","author":"Adrogu\u00e9 HJ","year":"2000","unstructured":"Adrogu\u00e9 HJ, Madias NE. Hyponatremia. N Engl J Med. 2000, 342:1581-9. 10.1056\/NEJM200005253422107","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2174\/1573403X15666190306111812","article-title":"Hyponatremia in heart failure: pathogenesis and management","volume":"15","author":"Rodriguez M","year":"2019","unstructured":"Rodriguez M, Hernandez M, Cheungpasitporn W, et al.. Hyponatremia in heart failure: pathogenesis and management. Curr Cardiol Rev. 2019, 15:252-61. 10.2174\/1573403X15666190306111812","journal-title":"Curr Cardiol Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S1575-0922(10)70021-8","article-title":"Vasopressin receptor antagonists: the vaptans [Article in Spanish]","volume":"57","author":"Villabona C","year":"2010","unstructured":"Villabona C. Vasopressin receptor antagonists: the vaptans [Article in Spanish]. Endocrinol Nutr. 2010, 57:41-52. 10.1016\/S1575-0922(10)70021-8","journal-title":"Endocrinol Nutr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.rceng.2024.12.001","article-title":"Comparative study of the effectiveness of tolvaptan versus urea in patients with hyponatremia caused by SIADH","volume":"225","author":"Mart\u00ednez Gonz\u00e1lez \u00c1","year":"2025","unstructured":"Mart\u00ednez Gonz\u00e1lez \u00c1, Gonz\u00e1lez Nunes M, Rodeiro Escobar P, et al.. Comparative study of the effectiveness of tolvaptan versus urea in patients with hyponatremia caused by SIADH. Rev Clin Esp (Barc). 2025, 225:85-91. 10.1016\/j.rceng.2024.12.001","journal-title":"Rev Clin Esp (Barc)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1159\/000446267","article-title":"Current challenges in the evaluation and management of hyponatremia","volume":"2","author":"McGreal K","year":"2016","unstructured":"McGreal K, Budhiraja P, Jain N, Yu AS. Current challenges in the evaluation and management of hyponatremia. Kidney Dis (Basel). 2016, 2:56-63. 10.1159\/000446267","journal-title":"Kidney Dis (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfae162","article-title":"Hyponatraemia-treatment standard 2024","volume":"39","author":"Spasovski G","year":"2024","unstructured":"Spasovski G. Hyponatraemia-treatment standard 2024. Nephrol Dial Transplant. 2024, 39:1583-92. 10.1093\/ndt\/gfae162","journal-title":"Nephrol Dial Transplant"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2021.02.003","article-title":"Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement","volume":"134","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement. J Clin Epidemiol. 2021, 134:103-12. 10.1016\/j.jclinepi.2021.02.003","journal-title":"J Clin Epidemiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/sja.SJA_767_17","article-title":"Appearance of population, intervention, comparison, and outcome as research question in the title of articles of three different anesthesia journals: a pilot study","volume":"12","author":"Eldawlatly A","year":"2018","unstructured":"Eldawlatly A, Alshehri H, Alqahtani A, Ahmad A, Al-Dammas F, Marzouk A. Appearance of population, intervention, comparison, and outcome as research question in the title of articles of three different anesthesia journals: a pilot study. Saudi J Anaesth. 2018, 12:283-6. 10.4103\/sja.SJA_767_17","journal-title":"Saudi J Anaesth"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins JP","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, et al.. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011, 343:d5928. 10.1136\/bmj.d5928","journal-title":"BMJ"},{"key":"ref12","unstructured":"The Ottawa Hospital Research Institute. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. (2021). Accessed: 2025: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea BJ","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, et al.. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017, 358:j4008. 10.1136\/bmj.j4008","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE's risk of bias tool for animal studies","volume":"14","author":"Hooijmans CR","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE's risk of bias tool for animal studies. BMC Med Res Methodol. 2014, 14:43. 10.1186\/1471-2288-14-43","journal-title":"BMC Med Res Methodol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-1078","article-title":"Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion","volume":"164","author":"Verbalis JG","year":"2011","unstructured":"Verbalis JG, Adler S, Schrier RW, Berl T, Zhao Q, Czerwiec FS. Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion. Eur J Endocrinol. 2011, 164:725-32. 10.1530\/EJE-10-1078","journal-title":"Eur J Endocrinol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-13-1020","article-title":"Clinical practice guideline on diagnosis and treatment of hyponatraemia","volume":"170","author":"Spasovski G","year":"2014","unstructured":"Spasovski G, Vanholder R, Allolio B, et al.. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol. 2014, 170:G1-47. 10.1530\/EJE-13-1020","journal-title":"Eur J Endocrinol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.805","article-title":"Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials","volume":"6","author":"Gralla RJ","year":"2017","unstructured":"Gralla RJ, Ahmad F, Blais JD, Chiodo J 3rd, Zhou W, Glaser LA, Czerwiec FS. Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials. Cancer Med. 2017, 6:723-9. 10.1002\/cam4.805","journal-title":"Cancer Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa065181","article-title":"Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia","volume":"355","author":"Schrier RW","year":"2006","unstructured":"Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, Orlandi C. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med. 2006, 355:2099-112. 10.1056\/NEJMoa065181","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016101139","article-title":"Diagnosis and treatment of hyponatremia: compilation of the guidelines","volume":"28","author":"Hoorn EJ","year":"2017","unstructured":"Hoorn EJ, Zietse R. Diagnosis and treatment of hyponatremia: compilation of the guidelines. J Am Soc Nephrol. 2017, 28:1340-9. 10.1681\/ASN.2016101139","journal-title":"J Am Soc Nephrol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.06990711","article-title":"Efficacy and tolerance of urea compared with vaptans for long-term treatment of patients with SIADH","volume":"7","author":"Soupart A","year":"2012","unstructured":"Soupart A, Coffernils M, Couturier B, Gankam-Kengne F, Decaux G. Efficacy and tolerance of urea compared with vaptans for long-term treatment of patients with SIADH. Clin J Am Soc Nephrol. 2012, 7:742-7. 10.2215\/CJN.06990711","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00723.2012","article-title":"Demeclocycline attenuates hyponatremia by reducing aquaporin-2 expression in the renal inner medulla","volume":"305","author":"Kortenoeven ML","year":"2013","unstructured":"Kortenoeven ML, Sinke AP, Hadrup N, Trimpert C, Wetzels JF, Fenton RA, Deen PM. Demeclocycline attenuates hyponatremia by reducing aquaporin-2 expression in the renal inner medulla. Am J Physiol Renal Physiol. 2013, 305:F1705-18. 10.1152\/ajprenal.00723.2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1177\/2042018812437561","article-title":"Clinical management of SIADH","volume":"3","author":"Gross P","year":"2012","unstructured":"Gross P. Clinical management of SIADH. Ther Adv Endocrinol Metab. 2012, 3:61-73. 10.1177\/2042018812437561","journal-title":"Ther Adv Endocrinol Metab"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/426195-decoding-hyponatremia-a-systematic-review-of-diagnostic-pathways-and-therapeutic-approaches-applied-when-correction-fails","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:13:39Z","timestamp":1762344819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/426195-decoding-hyponatremia-a-systematic-review-of-diagnostic-pathways-and-therapeutic-approaches-applied-when-correction-fails"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.96131","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,5]]}}}